Optimizing suicide gene therapy for head and neck cancer

Laryngoscope

Volumn 107, Issue 11, 1997, Pages 1490-1495

  Sewell, Duane A ^a   Li, Daqing ^a   Duan, Ling ^a   Schwartz, Mary R ^b   O’Malley, Bert W ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; GENE THERAPY; HEAD AND NECK CANCER; HERPES SIMPLEX VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE; TRANSACTIVATION; TUMOR REGRESSION; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, DRUG; GANCICLOVIR; GENE THERAPY; HERPES SIMPLEX; HUMANS; MICE; MITOTIC INDEX; SALIVARY GLAND NEOPLASMS; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 0030781002     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-199711000-00012     Document Type: Article

References (19)

1. American Cancer Society Facts and Figures. Publ. No 93-400. Washington, DC: American Cancer Society; 1993.
2. Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med 1993;328:184-91.
3. Ervin TJ, Clark JR, Weichselbaum RR, et al. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 1987;5:10-20.
4. Larson DL, Lindberg RD, Lane E, et al. Major complications of radiotherapy in cancer of the oral cavity and oropharynx. Am J Surg 1983;146:531-6.
5. O’Malley BW Jr., Chen S-H, Schwartz MR, et al. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 1995; 55:1080-5.
6. O'Malley, BW Jr., Cope KA, Chen S-H, et al. Combination gene therapy for oral cancer in a murine model. Cancer Res 1996; 56:1737-41.
7. Matthews T, Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev Infect Dis 1988;10:s490-4.
8. Knowles MR, Hohneker KW, Zhou Z, et al. A controlled study of adenoviral vector mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 1995;333:823-31.
9. Yei S, Mittereder N, Wert S, et al. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum Gene Ther 1994;5:731-44.
10. Simon RH, Engelhardt JF, Yang Y, et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther 1993;4:771-80.
11. Chen S-H, Shine D, Goodman JC, et al. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vitro. Proc Natl Acad Sci U S A 1994;91:3054-7.
12. Oldfield EH, Ram Z, Culver KW, et al. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993;4:39-69.
13. Culver KW, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992;256: 1550-2.
14. Graham F, Prevec L. Methods in Molecular Biology: Gene Transfer and Expression Protocols. vol 7. Clifton, NJ: Humana Press, Inc.; 1991.
15. Crystal RG, McElvaney NG, Rosenfeld MA, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994;8:42-51.
16. Dai Y, Schwarz EM, Gu D, et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long term expression. Proc Natl Acad Sci U S A 1995;92:1401-5.
17. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Co.; 1996:2103-10.
18. Keay S, Bissett J, Merigan TC. Ganciclovir treatment of cytomegalovirus infection in iatrogenically immunocompromised patients. J Infect Dis 1987;156:1016.
19. USP Dispensing Information. Taunton, MA: Rand McNally; 1996:1528-32